beta

GERN

Geron Corp.

Gern

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.

Market Cap: 279 Million

Primary Exchange: NASDAQ

Website: http://www.geron.com

Shares Outstanding: 188 Million

Float: 188 Million

Dividend: (%)

Beta: 1.55169008507899

Sector: Health Technology

Industry: Biotechnology

Short Interest (Jan 12, 2018): 32.8 Million

Ethical Flags

Animal testing

Longest drawdown: 1081 trading days

From: 2013-12-05 To: 2018-03-23

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud